Yet they put their other drug as more advanced with key inflection points for the company in H1 & H2 2017 - 1103 still unsure whether they will be able to go straight to Phase III or another Phase II first. Like always in bio space it's a slow game.
ANP Price at posting:
8.3¢ Sentiment: None Disclosure: Held
